oxcarbazepine has been researched along with Nervous System Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fadda, V; Giovannelli, F; Maratea, D; Verrotti, A; Zaccara, G | 1 |
| Chen, CY; Liu, JL; Xiao, F | 1 |
| Best, B; Capparelli, E; Goicoechea, M; Haubrich, R | 1 |
| Gram, L; Rogvi-Hansen, B | 1 |
2 review(s) available for oxcarbazepine and Nervous System Disorders
| Article | Year |
|---|---|
Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Topics: Acetamides; Anticonvulsants; Ataxia; Carbamazepine; Dibenzazepines; Diplopia; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lacosamide; Nervous System Diseases; Oxcarbazepine; Randomized Controlled Trials as Topic; Risk Assessment; Sodium Channel Blockers; Treatment Outcome | 2013 |
Adverse effects of established and new antiepileptic drugs: an attempted comparison.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Nervous System Diseases; Oxcarbazepine; Phenobarbital; Phenytoin; Sleep Stages; Vigabatrin | 1995 |
2 other study(ies) available for oxcarbazepine and Nervous System Disorders
| Article | Year |
|---|---|
Superficial siderosis of the central nervous system with seizures onset.
Topics: Ataxia; Carbamazepine; Carcinoma; Central Nervous System; Diagnosis, Differential; Female; Gait; Humans; Magnetic Resonance Imaging; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nervous System Diseases; Oxcarbazepine; Radiotherapy; Seizures; Siderosis | 2015 |
Concurrent use of efavirenz and oxcarbazepine may not affect efavirenz plasma concentrations.
Topics: Adult; Alkynes; Anti-HIV Agents; Anticonvulsants; Benzoxazines; Bipolar Disorder; Carbamazepine; Cyclopropanes; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; HIV Infections; Humans; Male; Mental Disorders; Nervous System Diseases; Oxazines; Oxcarbazepine; Treatment Failure; Viral Load | 2006 |